Review





Similar Products

recombinant human her  (Sino Biological)
95
Sino Biological recombinant human her
Recombinant Human Her, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human her/product/Sino Biological
Average 95 stars, based on 1 article reviews
recombinant human her - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
her2 neu  (Shanghai Korain Biotech Co Ltd)
94
Shanghai Korain Biotech Co Ltd her2 neu
Her2 Neu, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 neu/product/Shanghai Korain Biotech Co Ltd
Average 94 stars, based on 1 article reviews
her2 neu - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
transgenic mouse model fvb/n-tg (mmtv-erbb2) nk1mul/j (her2/neu)  (Jackson Laboratory)
90
Jackson Laboratory transgenic mouse model fvb/n-tg (mmtv-erbb2) nk1mul/j (her2/neu)
Transgenic Mouse Model Fvb/N Tg (Mmtv Erbb2) Nk1mul/J (Her2/Neu), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transgenic mouse model fvb/n-tg (mmtv-erbb2) nk1mul/j (her2/neu)/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
transgenic mouse model fvb/n-tg (mmtv-erbb2) nk1mul/j (her2/neu) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
lightmix kit her2/neu tib  (TIB MOLBIOL)
90
TIB MOLBIOL lightmix kit her2/neu tib
Lightmix Kit Her2/Neu Tib, supplied by TIB MOLBIOL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lightmix kit her2/neu tib/product/TIB MOLBIOL
Average 90 stars, based on 1 article reviews
lightmix kit her2/neu tib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mca1788 rrid ab 322791  (Bio-Rad)
93
Bio-Rad mca1788 rrid ab 322791
Mca1788 Rrid Ab 322791, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mca1788 rrid ab 322791/product/Bio-Rad
Average 93 stars, based on 1 article reviews
mca1788 rrid ab 322791 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
her2  (Santa Cruz Biotechnology)
95
Santa Cruz Biotechnology her2
Fig. 6 Ezrin and NHERF1 are required for Erbin and <t>HER2</t> interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com
Her2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
her2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
mca1788  (Bio-Rad)
93
Bio-Rad mca1788
Fig. 6 Ezrin and NHERF1 are required for Erbin and <t>HER2</t> interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com
Mca1788, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mca1788/product/Bio-Rad
Average 93 stars, based on 1 article reviews
mca1788 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti her2  (Bio-Rad)
93
Bio-Rad anti her2
Fig. 6 Ezrin and NHERF1 are required for Erbin and <t>HER2</t> interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com
Anti Her2, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti her2/product/Bio-Rad
Average 93 stars, based on 1 article reviews
anti her2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti-her2/neu sp3 rabbit monoclonal antibody  (Cell Marque)
90
Cell Marque anti-her2/neu sp3 rabbit monoclonal antibody
Fig. 6 Ezrin and NHERF1 are required for Erbin and <t>HER2</t> interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com
Anti Her2/Neu Sp3 Rabbit Monoclonal Antibody, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-her2/neu sp3 rabbit monoclonal antibody/product/Cell Marque
Average 90 stars, based on 1 article reviews
anti-her2/neu sp3 rabbit monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 6 Ezrin and NHERF1 are required for Erbin and HER2 interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com

Journal: Breast cancer research : BCR

Article Title: Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer.

doi: 10.1186/s13058-025-02025-6

Figure Lengend Snippet: Fig. 6 Ezrin and NHERF1 are required for Erbin and HER2 interactions. A) Immunofluorescence for Erbin with HER2 (top row), NHERF1 (middle row), and Ezrin (bottom row) in NSC668394 treated SKBR3 cells. All scale bars represent 10µM. B) Immunofluorescence for Erbin with HER2 (top row) and Ezrin (bot tom row) in NHERF1 knockdown SKBR3 cells. All scale bars represent 10µM. C) PLA fluorescence showing protein-protein interactions between HER2/ Erbin, Erbin/NHERF1, or Erbin/Ezrin in control, NSC668394 treated-, and NHERF1 knock-down SKBR3 cells. All scale bars represent 10µM. (n = 3) D) Quan tification of PLA results was performed by measuring the fluorescent intensity of PLA signals at the cell surface. HER2/Erbin (control n = 14, NSC668394 n = 14, NHERF1KD n = 14), Erbin/NHERF1 (control n = 19, NSC668394 n = 19, NHERF1KD n = 19), Erbin/EZRIN (control n = 15, NSC668394 n = 15, NHERF1KD n = 15). Bar graphs represent the mean ± SEM. **** denotes p < 0.00005. (n = 3). E) A working model proposing how HER2 mediated disruption of apical/ basal polarity creates the opportunity for the formation of a multi-protein signaling complex that includes HER2, Erbin, PMCA2, NHERF1, and Ezrin. Cre ated with BioRender.com

Article Snippet: Primary antibodies were against: HER2 (sc33684), mouse β-actin (sc-69879) from Santa Cruz (Dallas, TX); EGFR (4267), phospho-EGFR (2234), phospho-HER2 (2247) from cell signaling (Danvers, MA).

Techniques: Immunofluorescence, Knockdown, Fluorescence, Protein-Protein interactions, Control, Disruption